PetIQ, Inc. (PETQ)
| Market Cap | 987.16M |
| Revenue (ttm) | 770.18M |
| Net Income (ttm) | -78.04M |
| Shares Out | 24.94M |
| EPS (ttm) | -3.24 |
| PE Ratio | n/a |
| Forward PE | 24.04 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 27 |
| Last Price | $37.08 |
| Previous Close | $34.87 |
| Change ($) | 2.21 |
| Change (%) | 6.34% |
| Day's Open | 34.34 |
| Day's Range | 34.10 - 37.75 |
| Day's Volume | 587,622 |
| 52-Week Range | 16.59 - 38.45 |
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on...
EAGLE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will parti...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2020 Results - Earnings Call Transcript
PetIQ (PETQ) delivered earnings and revenue surprises of -168.75% and -2.89%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the t...
PetIQ (PETQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PetIQ (PETQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EAGLE, Idaho, Oct. 22, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for...
Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter
PetIQ shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Stock Upgrades: PetIQ Shows Rising Relative Strength appeared first on Investor's Busines...
PetIQ's (PETQ) CEO Cord Christensen on Q2 2020 Results - Earnings Call Transcript
The company achieved record revenue in the second quarter, but is guiding for declines.
Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EAGLE, Idaho, July 23, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results f...
Expects to Complete Accretive, Strategic Transaction on July 31, 2020
EAGLE, Idaho, June 16, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will par...
PetIQ (PETQ) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Proceeds to be Used to Fund Capstar Acquisition Capped Call to Increase Effective Conversion Price to $41.51 (75% Effective Conversion Premium)
EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject to market and other conditions, $125,000,000 aggregate ...
EAGLE, Idaho, May 12, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the launch of its telehea...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q1 2020 Results - Earnings Call Transcript
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.
PetIQ (PETQ) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
Spot and Fluffy are living the good life -- invest so you can too.
EAGLE, Idaho, March 20, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that out of an abundanc...
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q4 2019 Results - Earnings Call Transcript
PetIQ (PETQ) delivered earnings and revenue surprises of -100.00% and 14.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Redfin, PetIQ, and Beyond Meat all have upcoming catalysts to propel their shares higher.
EAGLE, Idaho, Feb. 03, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Laure...
Celebrated 20 Wellness Center Openings in December Opened 80 Locations Across 22 States in 2019 at 5 Host Partner Locations Reaffirms 2019 Guidance Presentation at the ICR Conference Today ...
Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and Further Bolsters Manufacturing Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Oppor...
Small-cap stocks have lagged the market of late but these 10 stocks to buy should be doing plenty of catching up.
Celebrated 34 Wellness Center Openings in November Opened 60 Locations Year-to-Date in 22 States On-Track to Add 80 New Wellness Centers in 2019
PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2019 Results - Earnings Call Transcript
Profitability analysis is considered one of the best possible ways to assess the prospects of a company.
Animal wellness company PetIQ Inc (NASDAQ: PETQ) handily beat expectations in its second-quarter report Thursday, mostly due to pet owners spending more money on their beloved animals.
PetIQ CEO talks strategic partnership with Chewy
PetIQ CEO Cord Christensen tells Jim Cramer companies partnership with Chewy helped drive earnings this quarter.
"Our partnerships with retailers has allowed us to access a population of pets and bring our mission forward of being advocates for those pet-parents," PetIQ CEO Cord Christensen tells Jim Cra...
PetIQ's (PETQ) CEO Cord Christensen on Q2 2019 Results - Earnings Call Transcript
PetIQ (PETQ) delivered earnings and revenue surprises of 150.00% and 13.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
In 2019, U.S. pet owners are expected to spend more than $75 billion dollars on their animals.
About PETQ
PetIQ operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental trea... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jul 21, 2017 |
| CEO McCord Christensen | Employees 1,866 |
| Stock Exchange NASDAQ | Ticker Symbol PETQ |
Financial Performance
In 2019, PetIQ, Inc.'s revenue was $709.43 million, an increase of 34.21% compared to the previous year's $528.61 million. Losses were -$11.45 million, 1,364.6% more than in 2018.
Analyst Forecasts
According to 6 analysts, the average rating for PetIQ, Inc. stock is "Strong Buy." The 12-month stock price forecast is 41.60, which is an increase of 12.19% from the latest price.